NasdaqCM - Delayed Quote USD
Turnstone Biologics Corp. (TSBX)
0.3345
-0.0222
(-6.22%)
At close: June 13 at 4:00:00 PM EDT
0.3389
+0.00
+(1.32%)
After hours: June 13 at 4:32:41 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.78M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| FMR LLC Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Jul 25, 2023 |
| JEREL DAVIS C Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 12.00 per share. | Indirect | 2,700,000 | Jul 25, 2023 |
| JEREL DAVIS C Director and Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Jul 25, 2023 |
| GUPTA RISHI Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 12.00 per share. | Indirect | 4,999,992 | Jul 20, 2023 |
| GUPTA RISHI Director and Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Jul 20, 2023 |
| ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 12.00 per share. | Indirect | 4,999,992 | Jul 20, 2023 |
| ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Jul 20, 2023 |
Related Tickers
2160.T GNI Group Ltd.
3,715.00
+1.09%
EMMA Emmaus Life Sciences, Inc.
0.0170
0.00%
ATHA Athira Pharma, Inc.
0.3040
-1.78%
PBLA Panbela Therapeutics, Inc.
0.3000
+18.11%
FENC Fennec Pharmaceuticals Inc.
7.93
-4.69%
RLYB Rallybio Corporation
0.3240
-1.88%
ASBPW Aspire Biopharma Holdings, Inc.
0.0324
+4.18%
KRON Kronos Bio, Inc.
0.8926
+1.43%
CRGX CARGO Therapeutics, Inc.
4.3900
-2.01%
GYRE Gyre Therapeutics, Inc.
7.99
-0.99%